Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02948088 · ClinicalTrials.gov registry record
Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project
A clinical trial of Giant Cell Tumors, sponsored by Daiichi Sankyo.
- Completed
- Registry status
- 183
- Enrollment target
- 15
- Study locations
NCT02948088 is a study of Giant Cell Tumors that has completed, run by Daiichi Sankyo. The registered enrollment target is 183 participants. The trial reports 15 study locations across 4 states.
The verdict
NCT02948088, a study of Giant Cell Tumors, has completed, sponsored by Daiichi Sankyo.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
- 15
- Study locations
Study Summary
TGCT is a rare disease that is difficult to manage, surgical resection is the primary treatment currently available. To date no disease registry exists and there is little data available detailing the management of patients with diffuse TGCT (d-TGCT), the burden of d-TGCT for patients (including pain, joint stiffness, swelling, reduced mobility and quality of life) or the economic impact of d-TGCT. This study aims to collect data by an observational disease registry involving no intervention to the patient or changes to investigators treatment decisions.
Conditions Studied
Study Locations (15)
Other
- Medizinische Universität Graz - Graz
- CHU Nantes - Nantes
- Westdeutsches Tumorzentrum - Essen
- Istituto Ortopedico Rizzoli - Bologna
- Istituto Nazionale Tumori-Foundazione IRCCS - Milan
- Leiden University Medical Center - Leiden
- Radboud universitair medisch centrum - Nijmegen
- Hospital Sant Pau - Barcelona
- Hospital Universitario Virgen del Rocio - Seville
- The Royal Marsden Hospital - London
- Nuffield Orthopaedic Centre - Oxford
California
- David Geffen School of Medicine at UCLA - Los Angeles
- University of California San Francisco - San Francisco
New York
- Memorial Sloan Kettering Cancer Center - New York
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2016-11-18 |
| Est. Completion | 2021-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02948088
The ClinicalTrials.gov registry entry for NCT02948088 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 183 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daiichi Sankyo, which has 236 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Giant Cell Tumors appearing as the primary indexed condition, and to 0 interventions.
NCT02948088 reports 15 study locations spanning 4 distinct geographic areas - top geographies include Other, California, New York.
Frequently Asked Questions
What is clinical trial NCT02948088 about?
NCT02948088 is a clinical study titled "Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project". TGCT is a rare disease that is difficult to manage, surgical resection is the primary treatment currently available. To date no disease registry exists and there is little data available detailing the management of patients with diffuse TGCT (d-TGCT), the burden of d-TGCT for patients (including pai...
What is the current status of trial NCT02948088?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2016-11-18. Estimated completion is 2021-03-11.
What conditions does trial NCT02948088 study?
This clinical trial studies the following conditions: Giant Cell Tumors.
Who is sponsoring clinical trial NCT02948088?
This trial is sponsored by Daiichi Sankyo, which has 236 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02948088 being conducted?
This trial has 15 study locations across California, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.